BRIACELL THERAPEUTICS CORP. Deferred Tax Assets, Tax Deferred Expense
BRIACELL THERAPEUTICS CORP. (BCTX) had Deferred Tax Assets, Tax Deferred Expense of $310.23 thousand as of 2025-07-31, per its 10-K filed 2025-10-16.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsTaxDeferredExpense · last filed 2025-10-16
- 2025-07-31: Deferred Tax Assets, Tax Deferred Expense $310.23K.
- 2024-07-31: Deferred Tax Assets, Tax Deferred Expense $376.98K.
- 2023-07-31: Deferred Tax Assets, Tax Deferred Expense $734.30K.
- 2022-07-31: Deferred Tax Assets, Tax Deferred Expense $1.11M.
| Period end | Deferred Tax Assets, Tax Deferred Expense |
|---|---|
| 2025-07-31 | $310.23K 10-K · filed 2025-10-16 |
| 2024-07-31 | $376.98K 10-K · filed 2025-10-16 |
| 2023-07-31 | $734.30K 10-K · filed 2024-10-29 |
| 2022-07-31 | $1.11M 10-K · filed 2023-10-25 |
| 2021-07-31 | $1.48M 10-K · filed 2022-10-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |